HESI RN
HESI RN Pharmacology 106a Questions
Extract:
Question 1 of 5
A client with cystitis receives a prescription for phenazopyridine. Which information should the nurse explain to the client about its therapeutic effect?
Correct Answer: B
Rationale: Phenazopyridine is a urinary analgesic that relieves pain and burning from irritated bladder mucosa. It does not kill bacteria, calm spasms, or require specific timing related to intercourse.
Question 2 of 5
A client who experiences migraine headaches reports having fewer headaches since using the herbal remedy feverfew. Which information is most important for the nurse to include in a teaching plan for this client?
Correct Answer: A
Rationale: Feverfew can increase bleeding risk with aspirin/NSAIDs, a critical interaction to highlight. Allergies, anxiety, and GI side effects are important but less urgent than drug interactions.
Question 3 of 5
The nurse is administering IV fluconazole to a client who has systemic candidiasis. After reviewing the client's diagnostic studies, the nurse identifies a rising trend in the liver enzyme levels for aspartate aminotransferase (AST). Which action should the nurse implement?
Correct Answer: D
Rationale: Rising AST suggests hepatotoxicity from fluconazole, requiring the dose to be held and the provider notified for evaluation. Continuing the infusion, notifying the pharmacy, or submitting a report are secondary to addressing potential liver damage.
Question 4 of 5
The nurse is planning to administer sucralfate to a client with peptic ulcer disease. Which action should the nurse include in this client's plan of care?
Correct Answer: C
Rationale: Sucralfate forms a protective barrier on ulcers and is most effective on an empty stomach. Electrolyte monitoring, Candida assessment, and once-daily dosing are not specific to sucralfate’s administration.
Question 5 of 5
A client who is receiving pregabalin for fibromyalgia reports experiencing tremors in the hands. Which action should the nurse implement?
Correct Answer: B
Rationale: Tremors are a potential side effect of pregabalin, warranting provider notification for possible dose adjustment. Anti-anxiety drugs, glucose levels, and blood pressure readings are not directly related to addressing tremors.